OCCLESTON BIOPHARMA LIMITED

Company Information
for the year from 1 January 2025 to 31 December 2025


Directors	OCCLESTON, Louise
	OCCLESTON, Nicholas


Registered Number	14544570 (England and Wales)

Balance Sheet as at
31 December 2025

	2025 £	2024 £


Current Assets	182,141	129,446
Creditors amounts falling due within one year	(181,809)	(128,606)
Net current assets (liabilities)	332	840

Total assets less current liabilities	332	840

Net assets (liabilities)	332	840
Capital and reserves	332	840

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Average number of employees
The average number of persons employed by the company in the period was 2 (previous period: 2).

The financial statements were approved and authorised for issue by the Board of Directors on 10 September 2026, and are signed on its behalf by:

OCCLESTON, Louise
Director

OCCLESTON, Nicholas
Director

Registered Company No. 14544570